Hideyuki Fukuda
About
In The Last Decade
Hideyuki Fukuda
32 papers receiving 980 citations
Peers
Comparison fields: 5 of 88
- Molecular Medicine 585
- Pharmacology 526
- Molecular Biology 451
- Epidemiology 305
- Infectious Diseases 168
Countries citing papers authored by Hideyuki Fukuda
This map shows the geographic impact of Hideyuki Fukuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Fukuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Fukuda more than expected).
Fields of papers citing papers by Hideyuki Fukuda
This network shows the impact of papers produced by Hideyuki Fukuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Fukuda. The network helps show where Hideyuki Fukuda may publish in the future.
Co-authorship network of co-authors of Hideyuki Fukuda
This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Fukuda. A scholar is included among the top collaborators of Hideyuki Fukuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Fukuda. Hideyuki Fukuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 14 | |
| 3 | 8 | |
| 4 | 63 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | 144 | |
| 8 | 34 | |
| 9 | 54 | |
| 10 | 44 | |
| 11 | 7 | |
| 12 | 6 | |
| 13 | 18 | |
| 14 | 5 | |
| 15 | 2 | |
| 16 | 65 | |
| 17 | 20 | |
| 18 | 44 | |
| 19 | [A specific protein inhibiting membrane permeation of chloramphenicol in Pseudomonas aeruginosa]. | 9 |
| 20 | 126 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.